Pharmacyte Biotech Inc (PMCB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 04/30
(Values in U.S. thousands)
| 04-2025 | 04-2024 | 04-2023 | 04-2022 | 04-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 30,656 | 334 | -4,316 | -4,239 | -3,551 |
| Accounts payable and accrued liabilities | 10 | 261 | -243 | 33 | -14 |
| Other Working Capital | 3,724 | 299 | -297 | 9 | -146 |
| Other Operating Activity | -37,368 | -3,045 | 1,062 | 80 | 380 |
| Operating Cash Flow | $-2,978 | $-2,152 | $-3,794 | $-4,117 | $-3,331 |
| Cash Flows From Investing Activities | |||||
| Other Investing Activity | -7,000 | -5,000 | 0 | 0 | 0 |
| Investing Cash Flow | $-7,000 | $-5,000 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 0 | 1 | 87,362 | 4,699 |
| Common Stock Repurchased | -2,542 | -28,198 | -13,561 | N/A | N/A |
| Other Financing Activity | -22,487 | 17,490 | 0 | -51 | -62 |
| Financing Cash Flow | $-25,029 | $-10,708 | $-13,560 | $87,311 | $4,637 |
| Exchange Rate Effect | 0 | -1 | -7 | 5 | 1 |
| Beginning Cash Position | 50,180 | 68,040 | 85,401 | 2,202 | 895 |
| End Cash Position | 15,172 | 50,180 | 68,040 | 85,401 | 2,202 |
| Net Cash Flow | $-35,008 | $-17,860 | $-17,361 | $83,199 | $1,307 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,978 | -2,152 | -3,794 | -4,117 | -3,331 |
| Free Cash Flow | -2,978 | -2,152 | -3,794 | -4,117 | -3,331 |